Diabetes Care, Vol 16, Issue 5 689-694, Copyright © 1993 by American Diabetes Association

ARTICLES

Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes

PJ Beisswenger, LL Moore and TJ Curphey
Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire.

OBJECTIVE--To evaluate the relationship between glycemic control over a 3-yr period and tissue levels of advanced glycosylation end products. The development of renal failure, blindness, and generalized vascular occlusion continue to be the most serious ravages of diabetes. Tissue glycosylation and AGEs are felt to play an important role in the development of these sequelae, but no data are available on the relationship between AGEs and long-term glycemic control. RESEARCH DESIGN AND METHODS--We studied 48 subjects with type I diabetes. Glycemic control was determined by mean levels of HbA1, and AGEs were determined on collagenase digests of skin collagen by fluorescence at excitation/emission readings of 335/385 and 370/440 nm. RESULTS--To evaluate the relationship between glycemic control and AGE levels, control was classified as good (< or = 8.5%), fair (> 8.5% but < or = 10%), or poor (> 10%) on the basis of mean HbA1 levels during 1- and 3-yr periods. Analysis of the mean AGE levels for each level of glycemic control over 1-3 yr showed that AGEs differed significantly across categories of glycemic control (P = 0.04 and 0.003), with the lowest AGE levels associated with good and the highest with poor glycemic control. The relationship also was highly significant when adjusted for age, sex, and duration of diabetes, and when examined by Pearson's correlation coefficients (P = 0.02 and 0.008). CONCLUSIONS--Finding a relationship between glycemic control over 1-3 yr and tissue levels of AGEs suggests that AGEs can be modified and possibly reversed by improved glucose levels.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Meerwaldt, H. L. Lutgers, T. P. Links, R. Graaff, J. W. Baynes, R. O.B. Gans, and A. J. Smit Skin Autofluorescence Is a Strong Predictor of Cardiac Mortality in Diabetes Diabetes Care, January 1, 2007; 30(1): 107 - 112. [Abstract] [Full Text] [PDF]

				M. T. Schram, C. G. Schalkwijk, A. H. Bootsma, J. H. Fuller, N. Chaturvedi, C. D.A. Stehouwer, and on behalf of the EURODIAB Prospective Complication Advanced Glycation End Products Are Associated With Pulse Pressure in Type 1 Diabetes: The EURODIAB Prospective Complications Study Hypertension, July 1, 2005; 46(1): 232 - 237. [Abstract] [Full Text] [PDF]

				D. R. SELL, N. R. KLEINMAN, and V. M. MONNIER Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice FASEB J, January 1, 2000; 14(1): 145 - 156. [Abstract] [Full Text]